Biotoxtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15,520	18,632	11,370	27,479	12,700	18,592
Short-Term Investments	10,000	9,500	19,000	13,559	17,059	9,559
Trading Asset Securities	-	-	2,014	-	1,012	-
Cash & Short-Term Investments	25,520	28,132	32,384	41,038	30,771	28,151
Cash Growth	-13.03%	-13.13%	-21.09%	33.37%	9.31%	32.97%
Accounts Receivable	8,102	8,700	7,863	5,355	7,352	5,813
Other Receivables	206	376.02	462.71	445.37	158.2	1,055
Receivables	11,035	11,803	9,918	8,392	10,261	8,631
Inventory	7,597	7,218	14,786	11,915	4,454	674.04
Prepaid Expenses	382.15	187.05	423.32	113.14	257.66	202.19
Other Current Assets	1,585	1,275	1,406	3,233	3,387	88.11
Total Current Assets	46,119	48,615	58,918	64,692	49,130	37,746
Property, Plant & Equipment	55,736	55,071	56,516	58,181	58,066	25,409
Long-Term Investments	19,027	18,902	10,320	10,689	10,130	18,373
Other Intangible Assets	1,188	1,276	1,665	1,596	1,483	1,479
Long-Term Deferred Tax Assets	944.12	732.72	1,852	5,344	1,072	565.72
Long-Term Deferred Charges	-	-	-	-	-	58.46
Other Long-Term Assets	2,850	2,815	2,093	1,865	819.42	2,110
Total Assets	130,059	131,607	136,191	147,036	125,700	90,741
Accounts Payable	728.95	687.72	673.72	541.98	783.54	815.54
Accrued Expenses	578.95	689.13	183.22	80.5	56	28.1
Short-Term Debt	46,894	46,037	42,818	41,229	27,853	23,843
Current Portion of Long-Term Debt	5,000	5,000	3,750	-	1,000	1,000
Current Portion of Leases	188.88	135.06	165.46	171.03	150.43	199.46
Current Income Taxes Payable	-	-	-	-	250.29	48.79
Current Unearned Revenue	4.59	11.46	-	-	-	-
Other Current Liabilities	34,049	32,932	34,619	33,096	29,435	19,841
Total Current Liabilities	87,444	85,492	82,210	75,119	59,528	45,777
Long-Term Debt	10,000	11,250	16,250	20,000	20,000	1,909
Long-Term Leases	109.69	77.91	65.74	191.59	136.81	97.13
Pension & Post-Retirement Benefits	3,036	2,671	3,041	3,320	1,508	1,070
Other Long-Term Liabilities	222.49	184.52	99.68	171.68	161.1	38.12
Total Liabilities	100,812	99,676	101,666	98,801	81,334	48,892
Common Stock	7,979	7,979	7,979	7,979	7,334	7,334
Additional Paid-In Capital	32,516	32,516	32,516	34,125	21,598	21,058
Retained Earnings	-710.73	1,161	58.56	6,740	12,162	9,354
Treasury Stock	-2,161	-2,161	-1,163	-165.68	-165.68	-165.68
Comprehensive Income & Other	674.66	662.67	691.38	3,032	3,307	3,563
Total Common Equity	38,298	40,157	40,082	51,710	44,235	41,144
Minority Interest	-9,051	-8,226	-5,557	-3,475	131.97	705.69
Shareholders' Equity	29,247	31,931	34,525	48,235	44,367	41,849
Total Liabilities & Equity	130,059	131,607	136,191	147,036	125,700	90,741
Total Debt	62,192	62,500	63,049	61,591	49,140	27,049
Net Cash (Debt)	-36,673	-34,367	-30,665	-20,553	-18,369	1,102
Net Cash Growth	-	-	-	-	-	-71.82%
Net Cash Per Share	-2359.19	-2199.82	-1932.30	-1332.10	-1255.03	71.58
Filing Date Shares Outstanding	15.41	15.41	15.72	15.93	14.64	14.64
Total Common Shares Outstanding	15.41	15.41	15.72	15.93	14.64	14.64
Working Capital	-41,324	-36,877	-23,292	-10,426	-10,398	-8,031
Book Value Per Share	2485.92	2606.61	2549.63	3246.60	3022.26	2811.05
Tangible Book Value	37,111	38,882	38,417	50,115	42,752	39,665
Tangible Book Value Per Share	2408.84	2523.81	2443.71	3146.42	2920.96	2710.03
Land	6,668	6,668	6,668	6,668	6,668	6,650
Buildings	51,834	51,817	51,808	51,458	51,213	22,710
Machinery	15,361	14,195	13,694	13,203	10,913	4,666
Construction In Progress	141.88	1.44	65	1.78	131.6	1,654